MTOR and breast cancer: Intriguingly, a common shared feature has been identified downstream in the proliferative pathway of BC cells: the hyperactivation of the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway irrespectively from the growth factor receptors status [2].